Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 10 OTHER 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Carboplatin 34 Paclitaxel 29 Radiotherapy 23 Cisplatin 23 Docetaxel 18 Pemetrexed 14 Gemcitabine 14 Radiosurgery 10 Bevacizumab 9 Magnetic Resonance Spectroscopy 7 Etoposide 7 Ramucirumab 6 Erlotinib Hydrochloride 6 Cetuximab 6 Specimen Handling 5 Gene Expression Profiling 5 durvalumab 4 cediranib 4 Vinorelbine 4 Polymerase Chain Reaction 4 Amplified Fragment Length Polymorphism Analysis 4 pembrolizumab 3 cemiplimab 3 Watchful Waiting 3 Taxes 3 Surgical Procedures, Operative 3 Radiotherapy, Conformal 3 Psychiatric Rehabilitation 3 Neoadjuvant Therapy 3 Fluorodeoxyglucose F18 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Carcinoma, Non-Small-Cell Lung × lenvatinib × Clear all

NCT06068153 2024-11-20

AMBER

ETOP IBCSG Partners Foundation

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡